Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04018495 · ClinicalTrials.gov registry record
STeP IT UP CF: STimulating ImProved Health And Well-being In CysTic Fibrosis
A clinical trial, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 21
- Enrollment target
NCT04018495: Completed study, sponsored by Medical College of Wisconsin.
NCT04018495 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04018495 has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
STeP IT UP CF: STimulating ImProved Health And Well-being In CysTic Fibrosis Using Integration Of Fitness Technology and Port CF. A pilot in integration of wearable fitness tracker data with existing health data provided by CF foundation Patient Registry (Port CF)
Primary Outcome
Descriptive statistics, such as mean for the number of days of use over the three month period
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2019-09-10 |
| Est. Completion | 2022-08-24 |
What the finished NCT04018495 record still lists
NCT04018495 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04018495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04018495 about?
NCT04018495 is a clinical study titled "STeP IT UP CF: STimulating ImProved Health And Well-being In CysTic Fibrosis". STeP IT UP CF: STimulating ImProved Health And Well-being In CysTic Fibrosis Using Integration Of Fitness Technology and Port CF. A pilot in integration of wearable fitness tracker data with existing health data provided by CF foundation Patient Registry (Port CF)
What is the current status of trial NCT04018495?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2019-09-10. Estimated completion is 2022-08-24.
Who is sponsoring clinical trial NCT04018495?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI